PURPOSE OF REVIEW: This review will discuss erectile dysfunction in prostate cancer patients following radical prostatectomy . It will focus on the prevalence and current treatments for erectile dysfunction as well as the emotional impact of erectile dysfunction and the current psychosocial interventions designed to help patients cope with this side effect. RECENT FINDINGS: Although there is a large discrepancy in prevalence rates of erectile dysfunction after radical prostatectomy, several recent studies have cited rates as high as 85%. The concept of 'penile rehabilitation' is now the standard of practice to treat erectile dysfunction following radical prostatectomy. However, many men avoid seeking help or utilizing erectile dysfunction treatments. This avoidance is related to the shame, frustration, and distress many men with erectile dysfunction and their partners experience. Recent psychosocial interventions have been developed to facilitate the use of treatments and help men cope with erectile dysfunction. These interventions have shown initial promise, however, continued intervention development is needed to reduce distress and improve long-term erectile function outcomes. SUMMARY: Erectile dysfunction is a significant problem following prostate cancer surgery. Although there are effective medical treatments, the development of psychosocial interventions should continue to evolve to maximize the assistance we can give to men and their partners.
PURPOSE OF REVIEW: This review will discuss erectile dysfunction in prostate cancerpatients following radical prostatectomy . It will focus on the prevalence and current treatments for erectile dysfunction as well as the emotional impact of erectile dysfunction and the current psychosocial interventions designed to help patients cope with this side effect. RECENT FINDINGS: Although there is a large discrepancy in prevalence rates of erectile dysfunction after radical prostatectomy, several recent studies have cited rates as high as 85%. The concept of 'penile rehabilitation' is now the standard of practice to treat erectile dysfunction following radical prostatectomy. However, many men avoid seeking help or utilizing erectile dysfunction treatments. This avoidance is related to the shame, frustration, and distress many men with erectile dysfunction and their partners experience. Recent psychosocial interventions have been developed to facilitate the use of treatments and help men cope with erectile dysfunction. These interventions have shown initial promise, however, continued intervention development is needed to reduce distress and improve long-term erectile function outcomes. SUMMARY:Erectile dysfunction is a significant problem following prostate cancer surgery. Although there are effective medical treatments, the development of psychosocial interventions should continue to evolve to maximize the assistance we can give to men and their partners.
Authors: F Montorsi; G Guazzoni; L F Strambi; L F Da Pozzo; L Nava; L Barbieri; P Rigatti; G Pizzini; A Miani Journal: J Urol Date: 1997-10 Impact factor: 7.450
Authors: Rodrigo Fernando Pereira; Yasmin Spaolonzi Daibs; Marcos Tobias-Machado; Antonio Carlos Lima Pompeo Journal: Clin Genitourin Cancer Date: 2011-07-13 Impact factor: 2.872
Authors: Eva Johansson; Gunnar Steineck; Lars Holmberg; Jan-Erik Johansson; Tommy Nyberg; Mirja Ruutu; Anna Bill-Axelson Journal: Lancet Oncol Date: 2011-08-05 Impact factor: 41.316
Authors: Leslie R Schover; Rachel T Fouladi; Carla L Warneke; Leah Neese; Eric A Klein; Craig Zippe; Patrick A Kupelian Journal: Cancer Date: 2002-10-15 Impact factor: 6.860
Authors: Ryan Dobbs; Elizabeth Kalmanek; Shawn Choe; Daniel A Harrington; Samuel I Stupp; Kevin T McVary; Carol A Podlasek Journal: Exp Neurol Date: 2018-11-02 Impact factor: 5.330
Authors: Shawn Choe; Christopher W Bond; Daniel A Harrington; Samuel I Stupp; Kevin T McVary; Carol A Podlasek Journal: Nanomedicine Date: 2016-09-06 Impact factor: 5.307
Authors: Sarah Martin; Jiangping Deng; Timothy Searl; Samuel Ohlander; Daniel A Harrington; Samuel I Stupp; Danuta Dynda; Kevin T McVary; Carol A Podlasek Journal: J Sex Med Date: 2022-06-23 Impact factor: 3.937
Authors: Ryan Dobbs; Shawn Choe; Elizabeth Kalmanek; Daniel A Harrington; Samuel I Stupp; Kevin T McVary; Carol A Podlasek Journal: Nanomedicine Date: 2018-07-04 Impact factor: 5.307
Authors: Sarah Martin; Daniel A Harrington; Samuel Ohlander; Samuel I Stupp; Kevin T McVary; Carol A Podlasek Journal: J Sex Med Date: 2021-03-09 Impact factor: 3.802
Authors: Marah Hehemann; Shawn Choe; Elizabeth Kalmanek; Daniel Harrington; Samuel I Stupp; Kevin T McVary; Carol A Podlasek Journal: Sci Rep Date: 2018-11-06 Impact factor: 4.379
Authors: Sarah Martin; Daniel A Harrington; Samuel Ohlander; Samuel I Stupp; Kevin T McVary; Carol A Podlasek Journal: Nanomedicine Date: 2021-07-24 Impact factor: 6.096